Paper Details
- Home
- Paper Details
Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
Author: Ostman-SmithIngegerd
Original Abstract of the Article :
Clinically overt hypertrophic cardiomyopathy is the most common cause of sudden unexpected death in childhood and has significantly higher sudden death mortality in the 8- to 16-year age range than in the 17- to 30-year age range. A combination of electrocardiographic risk factors (a limb-lead ECG v...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/j.1472-8206.2010.00869.x
データ提供:米国国立医学図書館(NLM)
Hypertrophic Cardiomyopathy: A Silent Killer in Children
Hypertrophic cardiomyopathy (HCM), a heart muscle disease, can be particularly dangerous in children and adolescents, increasing the risk of sudden cardiac death. This research focuses on strategies to prevent sudden death in children with HCM. The authors discuss the importance of identifying high-risk patients based on electrocardiographic risk factors and septal wall thickness. They also emphasize the role of beta-blockers, particularly lipophilic beta-blockers, in reducing the risk of sudden death. The study also discusses the potential benefits and risks of other treatments, such as disopyramide, calcium-channel blockers, amiodarone, and internal cardioverter defibrillators.
Preventing Sudden Death: A Multifaceted Approach
The study emphasizes the importance of early detection and risk stratification in managing HCM in children. Identifying high-risk patients through ECG and septal wall thickness measurements allows for targeted interventions to reduce the risk of sudden cardiac death. The study highlights the crucial role of beta-blockers, particularly lipophilic beta-blockers, in reducing the risk of sudden death in these patients.
HCM in Children: A Complex Challenge
This research highlights the challenges of managing HCM in children and adolescents. The study emphasizes the importance of careful patient selection, appropriate treatment strategies, and ongoing monitoring to minimize the risk of sudden cardiac death. Understanding the diverse risk factors and treatment options for HCM in children is crucial for ensuring the health and safety of these vulnerable individuals.
Dr. Camel's Conclusion
This research provides essential information for healthcare professionals managing HCM in children and adolescents. The study highlights the critical need for early detection, risk stratification, and appropriate treatment strategies to prevent sudden cardiac death. The study's findings emphasize the importance of ongoing research and collaborative efforts to improve the management of HCM in children and adolescents, ultimately contributing to healthier and safer futures for these individuals.
Date :
- Date Completed 2011-01-05
- Date Revised 2020-12-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.